Niels P. Bergsland PhD

Niels P. Bergsland
PhD

Assistant Professor

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Ageing; Artificial Intelligence; Biomedical Image Analysis; Biomedical Imaging; Biomedical Imaging; Brain Research; Image Analysis; Image Processing and Analysis; Imaging In Vivo; Inflammation; Inflammation; Magnetic Resonance Imaging (MRI) – High Resolution; Movement Disorders; MRI Methodology; Multiple Sclerosis; Muscle disease; Myelin Diseases; Neurobiology; Neurodegenerative Diseases; Neurodegenerative disorders; Neuroimaging Analysis; Neurology; Neuroradiology; Parkinson’s disease; Parkinson’s Disease; Quantitative Susceptibility Mapping; Quantitative Susceptibility Mapping; Radiology

Contact Information

77 Goodell St. Suite 440D
Buffalo, New York 14203
npb5@buffalo.edu

View map

Overview Research Publications Activities Latest News

Professional Summary:

With a background in computer science and image processing, my research focuses on the development and application of computational methods and tools for quantitative clinical neuroimaging. I have worked to develop new methods to better predict the onset, progression, and treatment of disease from multiparametric magnetic resonance imaging (MRI), as well as to more quickly and accurately determine outcomes in clinical trials based on new imaging biomarkers. I have also extensively investigated imaging measures of neuroinflammation, neurodegeneration, and repair in multiple sclerosis to help more fully elucidate the underlying mechanisms and dynamics of the disease. More broadly, I have collaborated with many clinical investigators to apply quantitative imaging methods to studies and trials in traumatic brain injury, neurovascular interventions, Parkinson’s disease, Alzheimer’s, and epilepsy. More recently, I have been involved in the development and application of quantitative imaging markers in the study of neuromuscular disorders as well.

Overall, my work strives to tie advanced research techniques back to clinically meaningful outcomes, with particular effort on eliminating barriers to their translation to routine clinical settings and imaging centers.

Education and Training:

PhD, Biomedical engineering, Politecnico di Milano (2016)
MS, Computer Science, Nova Southeastern University (2012)
BA, Psychology, State University of New York at Buffalo (2005)

Employment:

Assistant professor, Department of Neurology, State University of New York at Buffalo (2023-present)
Integration Director, Buffalo Neuroimaging Analysis Center (2011-present)
Researcher, IRCCS Fondazione Don Carlo Gnocchi ONLUS (2013–2022)
Computer Scientist, Buffalo Neuroimaging Analysis Center (2004–2011)

Awards and Honors:

Distinguished reviewer for American Journal of Neuroradiology (2024)
Reviewer with Special Distinction for Journal of Magnetic Resonance Imaging (2020)
Top peer reviewer as per publons.com (2019)
Top peer reviewer as per publons.com (2018)
Reviewer with Special Distinction for Journal of Magnetic Resonance Imaging (2018)
Top peer reviewer as per publons.com (2017)
Reviewer with Special Distinction for Journal of Magnetic Resonance Imaging (2017)
Travel Grant Award from European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (2016)
Travel Grant Award from European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (2015)
Best Oral Presentation by a Young Investigator at European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (2015)
Director of the quarter in Buffalo Neuroimaging Analysis Center (2012)
Employee of the quarter in Buffalo Neuroimaging Analysis Center (2010)

Research Centers:

Buffalo Neuroimaging Analysis Center

UB 2020 Strategic Strengths:

Health and Wellness Across the Lifespan
Information and Computing Technology

Journal Articles:

Zivadinov R, Schweser F, Jakimovski D, Bergsland N, Dwyer MG. (2024) Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging. Neuroimaging clinics of North America (Aug), 34(3): 453-468.
Barzaghi L, Paoletti M, Monforte M, Bortolani S, Bonizzoni C, Thorsten F, Bergsland N, Santini F, Deligianni X, Tasca G, Ballante E, Figini S, Ricci E, Pichiecchio A. (2024) Muscle diffusion tensor imaging in facioscapulohumeral muscular dystrophy. Muscle & nerve (Aug), 70(2): 248-256.
Jakimovski D, Qureshi F, Ramanathan M, Keshavan A, Leyden K, Jalaleddini K, Ghoreyshi A, Dwyer MG, Bergsland N, Marr K, Weinstock-Guttman B, Zivadinov R. (2024) Lower arterial cerebral blood flow is associated with worse neuroinflammation and immunomodulation composite proteomic scores. Multiple sclerosis and related disorders (Jul), 87: 105687.
Fuchs TA, Zivadinov R, Pryshchepova T, Weinstock-Guttman B, Dwyer MG, Benedict RHB, Bergsland N, Jakimovski D, Uher T, Jelgerhuis JR, Barkhof F, Uitdehaag BMJ, Killestein J, Strijbis EMM, Schoonheim MM. (2024) Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis. Multiple sclerosis and related disorders (Jul), 89: 105755.
Jakimovski D, Weinstock-Guttman B, Burnham A, Weinstock Z, Wicks TR, Ramanathan M, Sciortino T, Ostrem M, Suchan C, Dwyer MG, Reilly J, Bergsland N, Schweser F, Kennedy C, Young-Hong D, Eckert SP, Hojnacki D, Benedict RH, Zivadinov R. (2024) Dynamic disability measures decrease the clinico-radiological gap in people with severely affected multiple sclerosis. Multiple sclerosis and related disorders (Jul), 87: 105630.
Jakimovski D, Zivadinov R, Qureshi F, Ramanathan M, Weinstock-Guttman B, Tavazzi E, Dwyer MG, Bergsland N. (2024) Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis. Biomolecules (Jul), 14(7). doi:10.3390/biom14070824
Bergsland N, Dwyer MG, Jakimovski D, Tavazzi E, Weinstock-Guttman B, Zivadinov R. (2024) Choroid plexus enlargement is associated with future periventricular neurodegeneration in multiple sclerosis. Multiple sclerosis and related disorders (Jul), 87: 105668.
Wicks TR, Jakimovski D, Reeves J, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R. (2024) Comorbid onset of cardiovascular diagnosis and long-term confirmed disability progression in multiple sclerosis: A 15-year follow-up study. Journal of the neurological sciences (Jul), 464: 123156.
Jakimovski D, Qureshi F, Ramanathan M, Jalaleddini K, Ghoreyshi A, Dwyer MG, Bergsland N, Weinstock-Guttman B, Zivadinov R. (2024) Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation. Journal of the neurological sciences (Jun), 461: 123055.
Zivadinov R, Jakimovski D, Burnham A, Kuhle J, Weinstock Z, Wicks TR, Ramanathan M, Sciortino T, Ostrem M, Suchan C, Dwyer MG, Reilly J, Bergsland N, Schweser F, Kennedy C, Young-Hong D, Eckert S, Hojnacki D, Benedict RHB, Weinstock-Guttman B. (2024) Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA-MS case-controlled study. Journal of neurology (May).
Zivadinov R, Pei J, Clayton D, Goldman DE, Winger RC, Cabatingan MS, Dwyer MG, Bergsland N. (2024) Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study. Journal of neurology, neurosurgery, and psychiatry (May), 95(6): 536-543.
Reeves JA, Mohebbi M, Wicks T, Salman F, Bartnik A, Jakimovski D, Bergsland N, Schweser F, Weinstock-Guttman B, Dwyer MG, Zivadinov R. (2024) Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years. Multiple sclerosis (Houndmills, Basingstoke, England) (Apr), 30(4-5): 535-545. doi:10.1177/13524585241229956
Jalaleddini K, Jakimovski D, Keshavan A, McCurdy S, Leyden K, Qureshi F, Ghoreyshi A, Bergsland N, Dwyer MG, Ramanathan M, Weinstock-Guttman B, Benedict RH, Zivadinov R. (2024) Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis. Annals of clinical and translational neurology (Mar), 11(3): 729-743. doi:10.1002/acn3.51996
Bartnik A, Singh S, Sum C, Smith M, Bergsland N, Zivadinov R, Dwyer MG. (2024) An Automated Tool to Classify and Transform Unstructured MRI Data into BIDS Datasets. Neuroinformatics (Mar).
Jakimovski D, Dorn RP, Regno MD, Bartnik A, Bergsland N, Ramanathan M, Dwyer MG, Benedict RHB, Zivadinov R, Szigeti K. (2024) Human restricted CHRFAM7A gene increases brain efficiency. Frontiers in neuroscience (Jan), 18: 1359028. doi:10.3389/fnins.2024.1359028
Jakimovski D, Zivadinov R, Weinstock Z, Burnham A, Wicks TR, Suchan C, Sciortino T, Schweser F, Bergsland N, Dwyer MG, Eckert SP, Young-Hong D, Weinstock-Guttman B, Benedict RHB. (2024) Cognitive function in severe progressive multiple sclerosis. Brain communications (Jan), 6(4): fcae226. doi:10.1093/braincomms/fcae226
Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Lorefice L, Schoonheim MM, Morrow SA, Ann Picone M, Pardo G, Zarif M, Gudesblatt M, Nicholas JA, Smith A, Hunter S, Newman S, AbdelRazek MA, Hoti I, Riolo J, Silva D, Fuchs TA, Dwyer MG, Hb Benedict R. (2024) Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis. NeuroImage. Clinical (Jan), 42: 103609. doi:10.1016/j.nicl.2024.103609
Tavazzi E, Zito A, Montomoli C, Bergsland N, Colombo E, La Malfa A, Bergamaschi R. (2023) A multiscale assessment of bowel impairment in an Italian multiple sclerosis cohort. Scientific reports (Dec), 13(1): 21960. doi:10.1038/s41598-023-48317-9
Weinstock ZL, Jaworski M, Dwyer MG, Jakimovski D, Burnham A, Wicks TR, Youngs M, Santivasci C, Cruz S, Gillies J, Covey TJ, Suchan C, Bergsland N, Weinstock-Guttman B, Zivadinov R, Benedict RH. (2023) Auditory Test of Processing Speed: Preliminary validation of a smartphone-based test of mental speed. Multiple sclerosis (Houndmills, Basingstoke, England) (Nov), 29(13): 1646-1658.
Jakimovski D, Zivadinov R, Weinstock Z, Fuchs TA, Bartnik A, Dwyer MG, Bergsland N, Weinstock-Guttman B, Benedict RHB. (2023) Cortical thickness and cognition in older people with multiple sclerosis. Journal of neurology (Nov), 270(11): 5223-5234.
Jaworski MG, Gillies JK, Youngs M, Wojcik C, Santivasci C, Jakimovski D, Bergsland N, Weinstock-Guttman B, Benedict RH. (2023) Predicting employment deterioration with the Processing Speed Test (PST) and SDMT in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Sep), 29(10): 1327-1336.
Bordin V, Pirastru A, Bergsland N, Cazzoli M, Baselli G, Baglio F. (2023) Optimal echo times for quantitative susceptibility mapping: A test-retest study on basal ganglia and subcortical brain nuclei. NeuroImage (Sep), 278: 120272.
Ganapathy Subramanian R, Zivadinov R, Bergsland N, Dwyer MG, Weinstock-Guttman B, Jakimovski D. (2023) Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis. Journal of neurology (Aug), 270(8): 3758-3769.
Reeves JA, Weinstock Z, Zivadinov R, Dwyer MG, Bergsland N, Salman F, Schweser F, Weinstock-Guttman B, Benedict RH, Jakimovski D. (2023) Paramagnetic rim lesions are associated with greater incidence of relapse and worse cognitive recovery following relapse. Multiple sclerosis (Houndmills, Basingstoke, England) (Jul), 29(8): 1033-1038. doi:10.1177/13524585231169466
Guttuso T, Shepherd R, Frick L, Feltri ML, Frerichs V, Ramanathan M, Zivadinov R, Bergsland N. (2023) Lithium's effects on therapeutic targets and MRI biomarkers in Parkinson. IBRO neuroscience reports (Jun), 14: 429-434. doi:10.1016/j.ibneur.2023.05.001
Bartnik A, Fuchs TA, Ashton K, Kuceyeski A, Li X, Mallory M, Oship D, Bergsland N, Ramasamy D, Jakimovski D, Benedict RHB, Weinstock-Guttman B, Zivadinov R, Dwyer MG. (2023) Functional alteration due to structural damage is network dependent: insight from multiple sclerosis. Cerebral cortex (New York, N.Y. : 1991) (May), 33(10): 6090-6102. doi:10.1093/cercor/bhac486
Bergsland N, Dwyer MG, Jakimovski D, Tavazzi E, Benedict RHB, Weinstock-Guttman B, Zivadinov R. (2023) Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis. Neurology (Feb), 100(9): e911-e920. doi:10.1212/WNL.0000000000201608
Pennington P, Weinstock-Guttman B, Kolb C, Jakimovski D, Sacca K, Benedict RHB, Eckert S, Stecker M, Lizarraga A, Dwyer MG, Schumacher CB, Bergsland N, Picco P, Bernitsas E, Zabad R, Pardo G, Negroski D, Belkin M, Hojnacki D, Zivadinov R. (2023) Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives. Journal of neurology (Feb), 270(2): 1095-1119.
Young N, Zivadinov R, Dwyer MG, Bergsland N, Weinstock-Guttman B, Jakimovski D. (2023) Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis. Diagnostics (Basel, Switzerland) (Feb), 13(4). doi:10.3390/diagnostics13040596
Jakimovski D, Wicks TR, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R. (2023) Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis. Degenerative neurological and neuromuscular disease (Jan), 13: 21-32. doi:10.2147/DNND.S384038
Vegezzi E, Cortese A, Bergsland N, Mussinelli R, Paoletti M, Solazzo F, Currò R, Ascagni L, Callegari I, Quartesan I, Lozza A, Deligianni X, Santini F, Marchioni E, Cosentino G, Alfonsi E, Tassorelli C, Bastianello S, Merlini G, Palladini G, Obici L, Pichiecchio A. (2023) Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study. Journal of neurology (Jan), 270(1): 328-339. doi:10.1007/s00415-022-11336-z
Colelli G, Barzaghi L, Paoletti M, Monforte M, Bergsland N, Manco G, Deligianni X, Santini F, Ricci E, Tasca G, Mira A, Figini S, Pichiecchio A. (2023) Radiomics and machine learning applied to STIR sequence for prediction of quantitative parameters in facioscapulohumeral disease. Frontiers in neurology (Jan), 14: 1105276. doi:10.3389/fneur.2023.1105276
Jakimovski D, Qureshi F, Ramanathan M, Gehman V, Keshavan A, Leyden K, Dwyer MG, Bergsland N, Weinstock-Guttman B, Zivadinov R. (2023) Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study. Brain communications (Jan), 5(3): fcad183. doi:10.1093/braincomms/fcad183
Oship D, Jakimovski D, Bergsland N, Horakova D, Uher T, Vaneckova M, Havrdova E, Dwyer MG, Zivadinov R. (2022) Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years. Multiple sclerosis and related disorders (Nov), 67: 104187.
Reeves JA, Bergsland N, Dwyer MG, Wilding GE, Jakimovski D, Salman F, Sule B, Meineke N, Weinstock-Guttman B, Zivadinov R, Schweser F. (2022) Susceptibility networks reveal independent patterns of brain iron abnormalities in multiple sclerosis. NeuroImage (Nov), 261: 119503. doi:10.1016/j.neuroimage.2022.119503
Jakimovski D, Zivadinov R, Bergsland N, Oh J, Martin M, Shinohara RT, Bakshi R, Calabresi PA, Papinutto N, Pelletier D, Dwyer MG. (2022) Multisite MRI reproducibility of lateral ventricular volume using the NAIMS cooperative pilot dataset. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Sep), 32(5): 910-919. doi:10.1111/jon.12998
Jakimovski D, Bergsland N, Dwyer MG, Choedun K, Marr K, Weinstock-Guttman B, Zivadinov R. (2022) Cerebral blood flow dependency on systemic arterial circulation in progressive multiple sclerosis. European radiology (Sep), 32(9): 6468-6479.
Carolus K, Fuchs TA, Bergsland N, Ramasamy D, Tran H, Uher T, Horakova D, Vaneckova M, Havrdova E, Benedict RHB, Zivadinov R, Dwyer MG. (2022) Time course of lesion-induced atrophy in multiple sclerosis. Journal of neurology (Aug), 269(8): 4478-4487.
Jakimovski D, Gibney BL, Marr K, Ramasamy DP, Dwyer MG, Bergsland N, Weinstock-Guttman B, Ramanathan M, Zivadinov R. (2022) Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients. European journal of neurology (Aug), 29(8): 2299-2308.
Jakimovski D, Zivadinov R, Pelizzari L, Dunne-Jaffe C, Browne RW, Bergsland N, Dwyer MG, Weinstock-Guttman B, Ramanathan M. (2022) Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis. Multiple sclerosis and related disorders (Jul), 63: 103906.
Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Benedict RHB, Riolo J, Silva D, Dwyer MG, . (2022) Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-word study is associated with disability progression. Journal of neurology, neurosurgery, and psychiatry (Jul).
Agosti A, Shaqiri E, Paoletti M, Solazzo F, Bergsland N, Colelli G, Savini G, Muzic SI, Santini F, Deligianni X, Diamanti L, Monforte M, Tasca G, Ricci E, Bastianello S, Pichiecchio A. (2022) Deep learning for automatic segmentation of thigh and leg muscles. Magma (New York, N.Y.) (Jun), 35(3): 467-483. doi:10.1007/s10334-021-00967-4
Fuchs TA, Vaughn CB, Benedict RHB, Weinstock-Guttman B, Bergsland N, Jakimovski D, Ramasamy D, Zivadinov R, Dwyer MG. (2022) Patient-Reported Outcome Severity and Emotional Salience Network Disruption in Multiple Sclerosis. Brain imaging and behavior (Jun), 16(3): 1252-1259.
Deligianni X, Santini F, Paoletti M, Solazzo F, Bergsland N, Savini G, Faggioli A, Germani G, Monforte M, Ricci E, Tasca G, Pichiecchio A. (2022) Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy. Scientific reports (May), 12(1): 7250. doi:10.1038/s41598-022-11147-2
Tavazzi E, Bergsland N, Pirastru A, Pelizzari L, Cazzoli M, Saibene FL, Navarro JS, Farina E, Comanducci A, Cecconi P, Baglio F. (2022) Brain plasticity after rehabilitation in a severe case of artery of Percheron stroke assessed with multimodal MR imaging. Neurocase (Apr), 28(2): 194-198.
Guttuso T, Sirica D, Tosun D, Zivadinov R, Pasternak O, Weintraub D, Baglio F, Bergsland N. (2022) Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society (Mar), 37(3): 490-501. doi:10.1002/mds.28886
Lyman C, Lee D, Ferrari H, Fuchs TA, Bergsland N, Jakimovski D, Weinstock-Guttmann B, Zivadinov R, Dwyer MG. (2022) MRI-based thalamic volumetry in multiple sclerosis using FSL-FIRST: Systematic assessment of common error modes. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Mar), 32(2): 245-252.
Baglio F, Pirastru A, Bergsland N, Cazzoli M, Tavazzi E. (2022) Neuroplasticity mediated by motor rehabilitation in Parkinson's disease: a systematic review on structural and functional MRI markers. Reviews in the neurosciences (Feb), 33(2): 213-226.
Tavazzi E, Bergsland N, Pirastru A, Cazzoli M, Blasi V, Baglio F. (2022) MRI markers of functional connectivity and tissue microstructure in stroke-related motor rehabilitation: A systematic review. NeuroImage. Clinical (Jan), 33: 102931. doi:10.1016/j.nicl.2021.102931
Isernia S, MacPherson SE, Baksh RA, Bergsland N, Marchetti A, Baglio F, Massaro D. (2022) Italian adaptation of the Edinburgh Social Cognition Test (ESCoT): A new tool for the assessment of theory of mind and social norm understanding. Frontiers in psychology (Jan), 13: 971187. doi:10.3389/fpsyg.2022.971187
Hildesheim FE, Benedict RHB, Zivadinov R, Dwyer MG, Fuchs T, Jakimovski D, Weinstock-Guttman B, Bergsland N. (2021) Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis. Journal of neurology (Dec), 268(12): 4796-4808. doi:10.1007/s00415-021-10594-7
Bergsland N, Pelizzari L, Laganá MM, Di Tella S, Rossetto F, Nemni R, Clerici M, Baglio F. (2021) Automated Assessment of the Substantia Nigra Pars Compacta in Parkinson's Disease: A Diffusion Tensor Imaging Study. Journal of personalized medicine (Nov), 11(11). doi:10.3390/jpm11111235
Uher T, Havrdova EK, Benkert P, Bergsland N, Krasensky J, Srpova B, Dwyer M, Tyblova M, Meier S, Vaneckova M, Horakova D, Zivadinov R, Leppert D, Kalincik T, Kuhle J. (2021) Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Nov), 27(13): 2001-2013.
Bhan A, Jacobsen C, Dalen I, Bergsland N, Zivadinov R, Alves G, Myhr KM, Farbu E. (2021) CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical (Oct), 7(4): 20552173211060337. doi:10.1177/20552173211060337
Muzic SI, Paoletti M, Solazzo F, Belatti E, Vitale R, Bergsland N, Bastianello S, Pichiecchio A. (2021) Reproducibility of manual segmentation in muscle imaging. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology (Sep), 40(3): 116-123. doi:10.36185/2532-1900-052
Bergsland N, Dwyer MG, Jakimovski D, Weinstock-Guttman B, Zivadinov R. (2021) Diffusion tensor imaging reveals greater microstructure damage in lesional tissue that shrinks into cerebrospinal fluid in multiple sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Sep), 31(5): 995-1002.
Jakimovski D, Dwyer MG, Bergsland N, Weinstock-Guttman B, Zivadinov R. (2021) Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives. Neurodegenerative disease management (Aug), 11(4): 329-340.
Jakimovski D, Benedict RHB, Weinstock-Guttman B, Ozel O, Fuchs TA, Lincoff N, Bergsland N, Dwyer MG, Zivadinov R. (2021) Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?. Journal of neurology (Jul), 268(7): 2578-2588.
Felisaz PF, Belatti E, Deligianni X, Bergsland N, Santini F, Paoletti M, Solazzo F, Germani G, Cortese A, Vegezzi E, Bieri O, Bastianello S, Pichiecchio A. (2021) Variable echo time imaging for detecting the short T2* components of the sciatic nerve: a validation study. Magma (New York, N.Y.) (Jun), 34(3): 411-419. doi:10.1007/s10334-020-00886-w
Uher T, Krasensky J, Malpas C, Bergsland N, Dwyer MG, Kubala Havrdova E, Vaneckova M, Horakova D, Zivadinov R, Kalincik T. (2021) Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation (May), 8(3). doi:10.1212/NXI.0000000000000979
Schweser F, Hagemeier J, Dwyer MG, Bergsland N, Hametner S, Weinstock-Guttman B, Zivadinov R. (2021) Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI. Human brain mapping (Apr), 42(5): 1463-1474. doi:10.1002/hbm.25306
Uher T, Bergsland N, Krasensky J, Dwyer MG, Andelova M, Sobisek L, Havrdova EK, Horakova D, Zivadinov R, Vaneckova M. (2021) Interpretation of Brain Volume Increase in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Mar), 31(2): 401-407.
Bergsland N, Benedict RHB, Dwyer MG, Fuchs TA, Jakimovski D, Schweser F, Tavazzi E, Weinstock-Guttman B, Zivadinov R. (2021) Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study. Journal of magnetic resonance imaging : JMRI (Mar), 53(3): 731-739.
Uher T, McComb M, Galkin S, Srpova B, Oechtering J, Barro C, Tyblova M, Bergsland N, Krasensky J, Dwyer M, Havrdova EK, Posova H, Vaneckova M, Zivadinov R, Horakova D, Kuhle J, Ramanathan M. (2021) Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Feb), 27(2): 220-231.
Laganà MM, Jakimovski D, Bergsland N, Dwyer MG, Baglio F, Zivadinov R. (2021) Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software. Diagnostics (Basel, Switzerland) (Feb), 11(2). doi:10.3390/diagnostics11020325
Dwyer M, Lyman C, Ferrari H, Bergsland N, Fuchs TA, Jakimovski D, Schweser F, Weinstock-Guttmann B, Benedict RHB, Riolo J, Silva D, Zivadinov R. (2021) DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis. NeuroImage. Clinical (Jan), 30: 102652. doi:10.1016/j.nicl.2021.102652
Savini G, Asteggiano C, Paoletti M, Parravicini S, Pezzotti E, Solazzo F, Muzic SI, Santini F, Deligianni X, Gardani A, Germani G, Farina LM, Bergsland N, Gandini Wheeler-Kingshott CAM, Berardinelli A, Bastianello S, Pichiecchio A. (2021) Pilot Study on Quantitative Cervical Cord and Muscular MRI in Spinal Muscular Atrophy: Promising Biomarkers of Disease Evolution and Treatment?. Frontiers in neurology (Jan), 12: 613834. doi:10.3389/fneur.2021.613834
Fuchs TA, Dwyer MG, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Hb Benedict R, Zivadinov R. (2021) Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI. NeuroImage. Clinical (Jan), 31: 102705. doi:10.1016/j.nicl.2021.102705
Di Tella S, Blasi V, Cabinio M, Bergsland N, Buccino G, Baglio F. (2021) How Do We Motorically Resonate in Aging? A Compensatory Role of Prefrontal Cortex. Frontiers in aging neuroscience (Jan), 13: 694676. doi:10.3389/fnagi.2021.694676
Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. (2021) Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis. Multiple sclerosis and related disorders (Jan), 47: 102653.
Santini F, Deligianni X, Paoletti M, Solazzo F, Weigel M, de Sousa PL, Bieri O, Monforte M, Ricci E, Tasca G, Pichiecchio A, Bergsland N. (2021) Fast Open-Source Toolkit for Water T2 Mapping in the Presence of Fat From Multi-Echo Spin-Echo Acquisitions for Muscle MRI. Frontiers in neurology (Jan), 12: 630387. doi:10.3389/fneur.2021.630387
Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Benedict RH, Bergsland N, Farbu E. (2021) Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study. Multiple sclerosis journal - experimental, translational and clinical (Jan), 7(1): 2055217321992394. doi:10.1177/2055217321992394
Jakimovski D, Zivadinov R, Bergsland N, Ramasamy DP, Hagemeier J, Genovese AV, Hojnacki D, Weinstock-Guttman B, Dwyer MG. (2021) Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes. NeuroImage. Clinical (Jan), 29: 102554. doi:10.1016/j.nicl.2020.102554
Barnett M, Bergsland N, Weinstock-Guttman B, Butzkueven H, Kalincik T, Desmond P, Gaillard F, van Pesch V, Ozakbas S, Rojas JI, Boz C, Altintas A, Wang C, Dwyer MG, Yang S, Jakimovski D, Kyle K, Ramasamy DP, Zivadinov R. (2021) Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study. NeuroImage. Clinical (Jan), 32: 102802. doi:10.1016/j.nicl.2021.102802
Paoletti M, Diamanti L, Muzic SI, Ballante E, Solazzo F, Foppoli L, Deligianni X, Santini F, Figini S, Bergsland N, Pichiecchio A. (2021) Longitudinal Quantitative MRI Evaluation of Muscle Involvement in Amyotrophic Lateral Sclerosis. Frontiers in neurology (Jan), 12: 749736. doi:10.3389/fneur.2021.749736
Ashton K, Fuchs TA, Oship D, Zivadinov R, Jakimovski D, Bergsland N, Ramasamy DP, Vaughn C, Weinstock-Guttman B, Benedict RHB, Dwyer MG. (2021) Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption. Journal of neurology (Jan), 268(1): 169-177.
Felisaz PF, Colelli G, Ballante E, Solazzo F, Paoletti M, Germani G, Santini F, Deligianni X, Bergsland N, Monforte M, Tasca G, Ricci E, Bastianello S, Figini S, Pichiecchio A. (2021) Texture analysis and machine learning to predict water T2 and fat fraction from non-quantitative MRI of thigh muscles in Facioscapulohumeral muscular dystrophy. European journal of radiology (Jan), 134: 109460.
Pirastru A, Pelizzari L, Bergsland N, Cazzoli M, Cecconi P, Baglio F, Laganà MM. (2020) Consistent Cerebral Blood Flow Covariance Networks across Healthy Individuals and Their Similarity with Resting State Networks and Vascular Territories. Diagnostics (Basel, Switzerland) (Nov), 10(11). doi:10.3390/diagnostics10110963
Jakimovski D, Zivadinov R, Dwyer MG, Bergsland N, Ramasamy DP, Browne RW, Weinstock-Guttman B, Ramanathan M. (2020) High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis. Journal of the neurological sciences (Nov), 418: 117120.
Jakimovski D, Dujmic D, Hagemeier J, Ramasamy DP, Bergsland N, Dwyer MG, Eckert S, Kolb C, Lizarraga A, Hojnacki D, Weinstock-Guttman B, Zivadinov R. (2020) Late onset multiple sclerosis is associated with more severe ventricle expansion. Multiple sclerosis and related disorders (Nov), 46: 102588.
McComb M, Parambi R, Browne RW, Bodziak ML, Jakimovski D, Bergsland N, Maceski A, Weinstock-Guttman B, Kuhle J, Zivadinov R, Ramanathan M. (2020) Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis. Multiple sclerosis and related disorders (Oct), 45: 102389.
Pelizzari L, Laganà MM, Baglio F, Bergsland N, Cecconi P, Viotti S, Pugnetti L, Nemni R, Baselli G, Clerici M, Mendozzi L. (2020) Cerebrovascular reactivity and its correlation with age in patients with multiple sclerosis. Brain imaging and behavior (Oct), 14(5): 1889-1898.
Fuchs TA, Benedict RH, Wilding G, Wojcik C, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG. (2020) Trait Conscientiousness predicts rate of brain atrophy in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Oct), 26(11): 1433-1436.
Tavazzi G, Bergsland N, Alcada J, Price S. (2020) Early signs of right ventricular systolic and diastolic dysfunction in acute severe respiratory failure: the importance of diastolic restrictive pattern. European heart journal. Acute cardiovascular care (Sep), 9(6): 649-656. doi:10.1177/2048872619883399
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Ramasamy DP, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. (2020) Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis. AJNR. American journal of neuroradiology (Sep), 41(9): 1577-1583. doi:10.3174/ajnr.A6684
Jakimovski D, Bergsland N, Dwyer MG, Ramasamy DP, Ramanathan M, Weinstock-Guttman B, Zivadinov R. (2020) Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis. Diagnostics (Basel, Switzerland) (Sep), 10(9). doi:10.3390/diagnostics10090685
Tavazzi E, Zivadinov R, Dwyer MG, Jakimovski D, Singhal T, Weinstock-Guttman B, Bergsland N. (2020) MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis. Expert review of neurotherapeutics (Aug), 20(8): 821-834.
Tavazzi E, Jakimovski D, Kuhle J, Hagemeier J, Ozel O, Ramanathan M, Barro C, Bergsland N, Tomic D, Kropshofer H, Leppert D, Michalak Z, Lincoff N, Dwyer MG, Benedict RHB, Weinstock-Guttman B, Zivadinov R. (2020) Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study. Neurology(R) neuroimmunology & neuroinflammation (Jul), 7(4). doi:10.1212/NXI.0000000000000737
Fuchs TA, Ziccardi S, Benedict RHB, Bartnik A, Kuceyeski A, Charvet LE, Oship D, Weinstock-Guttman B, Wojcik C, Hojnacki D, Kolb C, Escobar J, Campbell R, Tran HD, Bergsland N, Jakimovski D, Zivadinov R, Dwyer MG. (2020) Functional Connectivity and Structural Disruption in the Default-Mode Network Predicts Cognitive Rehabilitation Outcomes in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Jul), 30(4): 523-530.
Uher T, Schaedelin S, Srpova B, Barro C, Bergsland N, Dwyer M, Tyblova M, Vodehnalova K, Benkert P, Oechtering J, Leppert D, Naegelin Y, Krasensky J, Vaneckova M, Kubala Havrdova E, Kappos L, Zivadinov R, Horakova D, Kuhle J, Kalincik T. (2020) Monitoring of radiologic disease activity by serum neurofilaments in MS. Neurology(R) neuroimmunology & neuroinflammation (Jul), 7(4). doi:10.1212/NXI.0000000000000714
Jakimovski D, Bergsland N, Dwyer MG, Hagemeier J, Ramasamy DP, Szigeti K, Guttuso T, Lichter D, Hojnacki D, Weinstock-Guttman B, Benedict RHB, Zivadinov R. (2020) Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer. Neurobiology of aging (Jun), 90: 84-92. doi:10.1016/j.neurobiolaging.2020.02.002
Jakimovski D, Zivadinov R, Bergsland N, Ramasamy DP, Hagemeier J, Weinstock-Guttman B, Kolb C, Hojnacki D, Dwyer MG. (2020) Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (May), 30(3): 342-350.
Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM, Tomic D, Hagemeier J, Kropshofer H, Leppert D, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R. (2020) A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. Journal of neurology (Mar), 267(3): 802-811.
Jakimovski D, Ramanathan M, Weinstock-Guttman B, Bergsland N, Ramasamay DP, Carl E, Dwyer MG, Zivadinov R. (2020) Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study. Multiple sclerosis (Houndmills, Basingstoke, England) (Mar), 26(3): 322-332. doi:10.1177/1352458519828667
Jakimovski D, Benedict RH, Marr K, Gandhi S, Bergsland N, Weinstock-Guttman B, Zivadinov R. (2020) Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients. Multiple sclerosis (Houndmills, Basingstoke, England) (Feb), 26(2): 201-209. doi:10.1177/1352458518819608
Ziliotto N, Zivadinov R, Baroni M, Marchetti G, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Straudi S, Manfredini F, Ramanathan M, Bernardi F. (2020) Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis. European journal of neurology (Feb), 27(2): 235-243. doi:10.1111/ene.14058
Pelizzari L, Di Tella S, Laganà MM, Bergsland N, Rossetto F, Nemni R, Baglio F. (2020) White matter alterations in early Parkinson's disease: role of motor symptom lateralization. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Feb), 41(2): 357-364.
Murali N, Browne RW, Fellows Maxwell K, Bodziak ML, Jakimovski D, Hagemeier J, Bergsland N, Weinstock-Guttman B, Zivadinov R, Ramanathan M. (2020) Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 years of follow-up. European journal of neurology (Jan), 27(1): 188-e4.
Pelizzari L, Di Tella S, Rossetto F, Laganà MM, Bergsland N, Pirastru A, Meloni M, Nemni R, Baglio F. (2020) Parietal Perfusion Alterations in Parkinson's Disease Patients Without Dementia. Frontiers in neurology (Jan), 11: 562. doi:10.3389/fneur.2020.00562
McComb M, Krikheli M, Uher T, Browne RW, Srpova B, Oechtering J, Maceski AM, Tyblova M, Jakimovski D, Ramasamy DP, Bergsland N, Krasensky J, Noskova L, Fialova L, Weinstock-Guttman B, Havrdova EK, Vaneckova M, Zivadinov R, Horakova D, Kuhle J, Ramanathan M. (2020) Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis. Journal of clinical lipidology (Jan), 14(5): 675-684.e2.
Laganà MM, Pirastru A, Pelizzari L, Rossetto F, Di Tella S, Bergsland N, Nemni R, Meloni M, Baglio F. (2020) Multimodal Evaluation of Neurovascular Functionality in Early Parkinson's Disease. Frontiers in neurology (Jan), 11: 831. doi:10.3389/fneur.2020.00831
Jakimovski D, Bergsland N, Dwyer MG, Traversone J, Hagemeier J, Fuchs TA, Ramasamy DP, Weinstock-Guttman B, Benedict RHB, Zivadinov R. (2020) Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients. Frontiers in neurology (Jan), 11: 700. doi:10.3389/fneur.2020.00700
Ziliotto N, Zivadinov R, Jakimovski D, Baroni M, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Ramanathan M, Marchetti G, Bernardi F. (2020) Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis. Frontiers in neurology (Jan), 11: 553616. doi:10.3389/fneur.2020.553616
Zivadinov R, Dwyer MG, Carl E, Poole EM, Cavalier S, Briassouli P, Bergsland N. (2020) Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS. Therapeutic advances in neurological disorders (Jan), 13: 1756286420970754. doi:10.1177/1756286420970754
Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Bergsland N, Farbu E. (2020) Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Multiple sclerosis journal - experimental, translational and clinical (Jan), 6(1): 2055217320902481. doi:10.1177/2055217320902481
Jakimovski D, Zivadinov R, Weinstock-Guttman B, Bergsland N, Dwyer MG, Lagana MM. (2020) Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy. Fluids and barriers of the CNS (Jan), 17(1): 9. doi:10.1186/s12987-020-0172-3
Fuchs TA, Benedict RHB, Bartnik A, Choudhery S, Li X, Mallory M, Oship D, Yasin F, Ashton K, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG. (2019) Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis. Human brain mapping (Dec), 40(18): 5231-5241. doi:10.1002/hbm.24768
Genovese AV, Hagemeier J, Bergsland N, Jakimovski D, Dwyer MG, Ramasamy DP, Lizarraga AA, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. (2019) Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis. Radiology (Nov), 293(2): 424-433. doi:10.1148/radiol.2019190306
Zivadinov R, Ramanathan M, Hagemeier J, Bergsland N, Ramasamy DP, Durfee J, Kolb C, Weinstock-Guttman B. (2019) Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis. Multiple sclerosis and related disorders (Nov), 36: 101388.
Bergsland N, Tavazzi E, Schweser F, Jakimovski D, Hagemeier J, Dwyer MG, Zivadinov R. (2019) Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders. CNS drugs (Nov), 33(11): 1073-1086. doi:10.1007/s40263-019-00668-6
Jakimovski D, Kuhle J, Ramanathan M, Barro C, Tomic D, Hagemeier J, Kropshofer H, Bergsland N, Leppert D, Dwyer MG, Michalak Z, Benedict RHB, Weinstock-Guttman B, Zivadinov R. (2019) Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study. Annals of clinical and translational neurology (Sep), 6(9): 1757-1770. doi:10.1002/acn3.50872
Dwyer MG, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Barnett MH, Wang C, Tomic D, Silva D, Zivadinov R. (2019) Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Sep), 29(5): 615-623.
Zivadinov R, Bergsland N, Hagemeier J, Ramasamy DP, Dwyer MG, Schweser F, Kolb C, Weinstock-Guttman B, Hojnacki D. (2019) Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS. Neurology (Aug), 93(6): e611-e623. doi:10.1212/WNL.0000000000007892
Lin F, Zivadinov R, Hagemeier J, Weinstock-Guttman B, Vaughn C, Gandhi S, Jakimovski D, Hulst HE, Benedict RH, Bergsland N, Fuchs T, Dwyer MG. (2019) Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition. Multiple sclerosis (Houndmills, Basingstoke, England) (Aug), 25(9): 1243-1254.
Bergsland N, Zivadinov R, Schweser F, Hagemeier J, Lichter D, Guttuso T. (2019) Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society (Jul), 34(7): 1006-1013. doi:10.1002/mds.27730
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. (2019) Aging and Brain Atrophy in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Jul), 29(4): 527-535.
Jakimovski D, Topolski M, Kimura K, Marr K, Gandhi S, Ramasamy DP, Bergsland N, Hagemeier J, Weinstock-Guttman B, Zivadinov R. (2019) Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena?. Clinical autonomic research : official journal of the Clinical Autonomic Research Society (Jun), 29(3): 329-338. doi:10.1007/s10286-018-0555-6
Felisaz PF, Poli A, Vitale R, Vitale G, Asteggiano C, Bergsland N, Callegari I, Vegezzi E, Piccolo L, Cortese A, Pichiecchio A, Bastianello S. (2019) MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDP. Journal of the neurological sciences (May), 400: 15-20.
Bergsland N, Ramasamy D, Tavazzi E, Hojnacki D, Weinstock-Guttman B, Zivadinov R. (2019) Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study. AJNR. American journal of neuroradiology (Apr), 40(4): 620-625. doi:10.3174/ajnr.A6011
Jakimovski D, Weinstock-Guttman B, Gandhi S, Guan Y, Hagemeier J, Ramasamy DP, Fuchs TA, Browne RW, Bergsland N, Dwyer MG, Ramanathan M, Zivadinov R. (2019) Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study. Journal of neurology (Apr), 266(4): 866-875.
Zivadinov R, Kresa-Reahl K, Weinstock-Guttman B, Edwards K, Burudpakdee C, Bergsland N, Dwyer MG, Khatri B, Thangavelu K, Chavin J, Mandel M, Cohan S. (2019) Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study. Journal of comparative effectiveness research (Apr), 8(5): 305-316.
Uher T, Vaneckova M, Krasensky J, Sobisek L, Tyblova M, Volna J, Seidl Z, Bergsland N, Dwyer MG, Zivadinov R, De Stefano N, Sormani MP, Havrdova EK, Horakova D. (2019) Pathological cut-offs of global and regional brain volume loss in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Apr), 25(4): 541-553.
Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B. (2019) Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. Journal of clinical medicine (Mar), 8(3). doi:10.3390/jcm8030344
Zivadinov R, Horakova D, Bergsland N, Hagemeier J, Ramasamy DP, Uher T, Vaneckova M, Havrdova E, Dwyer MG. (2019) A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS. AJNR. American journal of neuroradiology (Mar), 40(3): 446-452. doi:10.3174/ajnr.A5987
Taege Y, Hagemeier J, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Schweser F. (2019) Assessment of mesoscopic properties of deep gray matter iron through a model-based simultaneous analysis of magnetic susceptibility and R2* - A pilot study in patients with multiple sclerosis and normal controls. NeuroImage (Feb), 186: 308-320. doi:10.1016/j.neuroimage.2018.11.011
Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B, . (2019) Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple sclerosis and related disorders (Jan), 27: 65-73.
Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy DP, Hojnacki D, Kolb C, Benedict RHB, Weinstock-Guttman B, Zivadinov R. (2019) Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study. European journal of neurology (Jan), 26(1): 87-e8.
Pelizzari L, Laganà MM, Rossetto F, Bergsland N, Galli M, Baselli G, Clerici M, Nemni R, Baglio F. (2019) Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease. Therapeutic advances in neurological disorders (Jan), 12: 1756286419838354. doi:10.1177/1756286419838354
Pelizzari L, Laganà MM, Di Tella S, Rossetto F, Bergsland N, Nemni R, Clerici M, Baglio F. (2019) Combined Assessment of Diffusion Parameters and Cerebral Blood Flow Within Basal Ganglia in Early Parkinson's Disease. Frontiers in aging neuroscience (Jan), 11: 134. doi:10.3389/fnagi.2019.00134
Ziliotto N, Zivadinov R, Jakimovski D, Baroni M, Tisato V, Secchiero P, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Bernardi F, Ramanathan M, Marchetti G. (2019) Plasma levels of soluble NCAM in multiple sclerosis. Journal of the neurological sciences (Jan), 396: 36-41.
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Silva D, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. (2018) Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine. AJNR. American journal of neuroradiology (Dec), 39(12): 2237-2242. doi:10.3174/ajnr.A5876
Zivadinov R, Tavazzi E, Bergsland N, Hagemeier J, Lin F, Dwyer MG, Carl E, Kolb C, Hojnacki D, Ramasamy D, Durfee J, Weinstock-Guttman B, Schweser F. (2018) Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis. Radiology (Nov), 289(2): 487-496. doi:10.1148/radiol.2018180136
Ziliotto N, Bernardi F, Jakimovski D, Baroni M, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zamboni P, Marchetti G, Zivadinov R, Ramanathan M. (2018) Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients. Multiple sclerosis and related disorders (Oct), 25: 37-42.
Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RHB, Zivadinov R. (2018) Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage. Journal of the neurological sciences (Oct), 393: 128-134.
Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R. (2018) Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study. Human brain mapping (Oct), 39(10): 4007-4017. doi:10.1002/hbm.24227
Pelizzari L, Jakimovski D, Laganà MM, Bergsland N, Hagemeier J, Baselli G, Weinstock-Guttman B, Zivadinov R. (2018) Five-Year Longitudinal Study of Neck Vessel Cross-Sectional Area in Multiple Sclerosis. AJNR. American journal of neuroradiology (Sep), 39(9): 1703-1709. doi:10.3174/ajnr.A5738
Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock-Guttman B, Zivadinov R. (2018) Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Sep), 28(5): 490-495.
Ziliotto N, Bernardi F, Jakimovski D, Baroni M, Marchetti G, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Schweser F, Zamboni P, Ramanathan M, Zivadinov R. (2018) Hemostasis biomarkers in multiple sclerosis. European journal of neurology (Sep), 25(9): 1169-1176.
Fuchs TA, Carolus K, Benedict RHB, Bergsland N, Ramasamy D, Jakimovski D, Weinstock-Guttman B, Kuceyeski A, Zivadinov R, Dwyer MG. (2018) Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study. AJNR. American journal of neuroradiology (Aug), 39(8): 1480-1486. doi:10.3174/ajnr.A5720
Zivadinov R, Medin J, Khan N, Korn JR, Bergsland N, Dwyer MG, Chitnis T, Naismith RT, Alvarez E, Kinkel P, Cohan S, Hunter SF, Silva D, Weinstock-Guttman B, . (2018) Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Jul), 28(4): 399-405.
Tavazzi E, Bergsland N, Cattaneo D, Gervasoni E, Laganà MM, Dipasquale O, Grosso C, Saibene FL, Baglio F, Rovaris M. (2018) Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study. Journal of neurology (Jun), 265(6): 1393-1401.
Zivadinov R, Bergsland N, Hagemeier J, Carl E, Kolb H, Hojnacki D, Weinstock-Guttman B. (2018) Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures. Journal of the neurological sciences (May), 388: 175-181.
Uher T, Krasensky J, Sobisek L, Seidl Z, Bergsland N, Dwyer MG, Kubala Havrdova E, Zivadinov R, Horakova D, Vaneckova M. (2018) The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (May), 28(3): 328-337.
Zivadinov R, Ramasamy DP, Hagemeier J, Kolb C, Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Hojnacki D. (2018) Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis. AJNR. American journal of neuroradiology (Apr), 39(4): 642-647. doi:10.3174/ajnr.A5541
Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B. (2018) Effect of switching from glatiramer acetate 20?mg/daily to glatiramer acetate 40?mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study. Journal of the neurological sciences (Apr), 387: 152-156.
Guttuso T, Bergsland N, Hagemeier J, Lichter DG, Pasternak O, Zivadinov R. (2018) Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease. AJNR. American journal of neuroradiology (Mar), 39(3): 479-484. doi:10.3174/ajnr.A5545
Zivadinov R, Hagemeier J, Bergsland N, Tavazzi E, Weinstock-Guttman B. (2018) Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study. European journal of neurology (Mar), 25(3): 584-e36.
Zivadinov R, Bergsland N, Korn JR, Dwyer MG, Khan N, Medin J, Price JC, Weinstock-Guttman B, Silva D, . (2018) Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS. AJNR. American journal of neuroradiology (Feb), 39(2): 289-295. doi:10.3174/ajnr.A5442
Schweser F, Raffaini Duarte Martins AL, Hagemeier J, Lin F, Hanspach J, Weinstock-Guttman B, Hametner S, Bergsland N, Dwyer MG, Zivadinov R. (2018) Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality. NeuroImage (Feb), 167: 438-452. doi:10.1016/j.neuroimage.2017.10.063
Bergsland N, Horakova D, Dwyer MG, Uher T, Vaneckova M, Tyblova M, Seidl Z, Krasensky J, Havrdova E, Zivadinov R. (2018) Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study. NeuroImage. Clinical (Jan), 17: 444-451. doi:10.1016/j.nicl.2017.11.002
Pelizzari L, Laganà MM, Jakimovski D, Bergsland N, Hagemeier J, Baselli G, Zivadinov R. (2018) Neck Vessel Cross-Sectional Area Measured with MRI: Scan-Rescan Reproducibility for Longitudinal Evaluations. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Jan), 28(1): 48-56. doi:10.1111/jon.12488
Hagemeier J, Ramanathan M, Schweser F, Dwyer MG, Lin F, Bergsland N, Weinstock-Guttman B, Zivadinov R. (2018) Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals. NeuroImage. Clinical (Jan), 17: 530-540. doi:10.1016/j.nicl.2017.11.003
Dwyer MG, Hagemeier J, Bergsland N, Horakova D, Korn JR, Khan N, Uher T, Medin J, Silva D, Vaneckova M, Havrdova EK, Zivadinov R. (2018) Establishing pathological cut-offs for lateral ventricular volume expansion rates. NeuroImage. Clinical (Jan), 18: 494-501. doi:10.1016/j.nicl.2018.02.009
Zivadinov R, Polak P, Schweser F, Bergsland N, Hagemeier J, Dwyer MG, Ramasamy DP, Baker JG, Leddy JJ, Willer BS. (2018) Multimodal Imaging of Retired Professional Contact Sport Athletes Does Not Provide Evidence of Structural and Functional Brain Damage. The Journal of head trauma rehabilitation (Jan), 33(5): E24-E32. doi:10.1097/HTR.0000000000000422
Laganá MM, Mendozzi L, Pelizzari L, Bergsland NP, Pugnetti L, Cecconi P, Baselli G, Clerici M, Nemni R, Baglio F. (2018) Are Cerebral Perfusion and Atrophy Linked in Multiple Sclerosis? Evidence for a Multifactorial Approach to Assess Neurodegeneration. Current neurovascular research (Jan), 15(4): 282-291.
Hagemeier J, Zivadinov R, Dwyer MG, Polak P, Bergsland N, Weinstock-Guttman B, Zalis J, Deistung A, Reichenbach JR, Schweser F. (2018) Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain. NeuroImage. Clinical (Jan), 18: 1007-1016. doi:10.1016/j.nicl.2017.04.008
Hanspach J, Dwyer MG, Bergsland NP, Feng X, Hagemeier J, Bertolino N, Polak P, Reichenbach JR, Zivadinov R, Schweser F. (2017) Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA). Journal of magnetic resonance imaging : JMRI (Nov), 46(5): 1474-1484. doi:10.1002/jmri.25671
Uher T, Krasensky J, Vaneckova M, Sobisek L, Seidl Z, Havrdova E, Bergsland N, Dwyer MG, Horakova D, Zivadinov R. (2017) A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Nov), 27(6): 620-629.
Zivadinov R, Ramasamy DP, Vaneckova M, Gandhi S, Chandra A, Hagemeier J, Bergsland N, Polak P, Benedict RH, Hojnacki D, Weinstock-Guttman B. (2017) Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study. Multiple sclerosis (Houndmills, Basingstoke, England) (Sep), 23(10): 1336-1345.
Woodward MR, Dwyer MG, Bergsland N, Hagemeier J, Zivadinov R, Benedict RH, Szigeti K. (2017) Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease. Psychiatry research. Neuroimaging (Aug), 266: 90-95. doi:10.1016/j.pscychresns.2017.06.004
Bergsland N, Agostini S, Laganà MM, Mancuso R, Mendozzi L, Tavazzi E, Cecconi P, Clerici M, Baglio F. (2017) Serum iron concentration is associated with subcortical deep gray matter iron levels in multiple sclerosis patients. Neuroreport (Aug), 28(11): 645-648.
Tavazzi G, Kontogeorgis A, Guarracino F, Bergsland N, Martinez-Naharro A, Pepper J, Price S. (2017) Heart Rate Modification of Cardiac Output Following Cardiac Surgery: The Importance of Cardiac Time Intervals. Critical care medicine (Aug), 45(8): e782-e788.
Zivadinov R, Khan N, Medin J, Christoffersen P, Price J, Korn JR, Bonzani I, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B. (2017) An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study. Journal of neuroimaging : official journal of the American Society of Neuroimaging (May), 27(3): 339-347. doi:10.1111/jon.12411
Belov P, Magnano C, Krawiecki J, Hagemeier J, Bergsland N, Beggs C, Zivadinov R. (2017) Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease. Phlebology (Mar), 32(2): 125-134.
Uher T, Fellows K, Horakova D, Zivadinov R, Vaneckova M, Sobisek L, Tyblova M, Seidl Z, Krasensky J, Bergsland N, Weinstock-Guttman B, Havrdova E, Ramanathan M. (2017) Serum lipid profile changes predict neurodegeneration in interferon-ß1a-treated multiple sclerosis patients. Journal of lipid research (Feb), 58(2): 403-411. doi:10.1194/jlr.M072751
Groppo E, Baglio F, Cattaneo D, Tavazzi E, Bergsland N, Di Tella S, Parelli R, Carpinella I, Grosso C, Capra R, Rovaris M. (2017) Multidisciplinary Rehabilitation is Efficacious and Induces Neural Plasticity in Multiple Sclerosis even when Complicated by Progressive Multifocal Leukoencephalopathy. Frontiers in neurology (Jan), 8: 491. doi:10.3389/fneur.2017.00491
Dwyer MG, Silva D, Bergsland N, Horakova D, Ramasamy D, Durfee J, Vaneckova M, Havrdova E, Zivadinov R. (2017) Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis. NeuroImage. Clinical (Jan), 15: 769-779. doi:10.1016/j.nicl.2017.06.022
Bergsland N, Tavazzi E, Laganà MM, Baglio F, Cecconi P, Viotti S, Zivadinov R, Baselli G, Rovaris M. (2017) White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging (Jan), 27(1): 107-113.
Zivadinov R, Ramasamy DP, Benedict RR, Polak P, Hagemeier J, Magnano C, Dwyer MG, Bergsland N, Bertolino N, Weinstock-Guttman B, Kolb C, Hojnacki D, Utriainen D, Haacke EM, Schweser F. (2016) Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study. Radiology (Dec), 281(3): 884-895.
Scaccianoce E, Laganà MM, Baglio F, Preti MG, Bergsland N, Cecconi P, Clerici M, Baselli G, Papadimitriou G, Makris N. (2016) Combined DTI-fMRI Analysis for a Quantitative Assessment of Connections Between WM Bundles and Their Peripheral Cortical Fields in Verbal Fluency. Brain topography (Nov), 29(6): 814-823.
Zivadinov R, Uher T, Hagemeier J, Vaneckova M, Ramasamy DP, Tyblova M, Bergsland N, Seidl Z, Dwyer MG, Krasensky J, Havrdova E, Horakova D. (2016) A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients. Multiple sclerosis (Houndmills, Basingstoke, England) (Nov), 22(13): 1709-1718.
Roy S, Schwartz CE, Duberstein P, Dwyer MG, Zivadinov R, Bergsland N, Powell V, Weinstock-Guttman B, Benedict RH. (2016) Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis. Journal of the International Neuropsychological Society : JINS (Oct), 22(9): 920-927.
Zivadinov R, Dwyer MG, Bergsland N. (2016) Brain atrophy measurements should be used to guide therapy monitoring in MS - YES. Multiple sclerosis (Houndmills, Basingstoke, England) (Oct), 22(12): 1522-1524.
Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B, Benedict RH. (2016) Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Multiple sclerosis (Houndmills, Basingstoke, England) (Sep), 22(10): 1327-36.
Hagemeier J, Woodward MR, Rafique UA, Amrutkar CV, Bergsland N, Dwyer MG, Benedict R, Zivadinov R, Szigeti K. (2016) Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy. Psychiatry research. Neuroimaging (Sep), 255: 87-93.
Tavazzi G, Kontogeorgis A, Bergsland NP, Price S. (2016) Resolution of Cardiogenic Shock Using Echocardiography-Guided Pacing Optimization in Intensive Care: A Case Series. Critical care medicine (Aug), 44(8): e755-61.
Schwartz CE, Dwyer MG, Benedict R, Weinstock-Guttman B, Bergsland NP, Li J, Ramanathan M, Zivadinov R. (2016) Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study. BMC neurology (Jul), 16: 108. doi:10.1186/s12883-016-0624-1
Zivadinov R, Jakimovski D, Gandhi S, Ahmed R, Dwyer MG, Horakova D, Weinstock-Guttman B, Benedict RR, Vaneckova M, Barnett M, Bergsland N. (2016) Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine. Expert review of neurotherapeutics (Jul), 16(7): 777-93.
Zivadinov R, Hojnacki D, Bergsland N, Kennedy C, Hagemeier J, Melia R, Ramasamy DP, Durfee J, Carl E, Dwyer MG, Weinstock-Guttman B. (2016) Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years. European journal of neurology (Jun), 23(6): 1101-9.
Zivadinov R, Raj B, Ramanathan M, Teter B, Durfee J, Dwyer MG, Bergsland N, Kolb C, Hojnacki D, Benedict RH, Weinstock-Guttman B. (2016) Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis. AJNR. American journal of neuroradiology (Jun), 37(6): 1010-6. doi:10.3174/ajnr.A4681
Kappus N, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Carl E, Ramasamy DP, Cherneva M, Durfee J, Bergsland N, Dwyer MG, Kolb C, Hojnacki D, Ramanathan M, Zivadinov R. (2016) Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (Feb), 87(2): 181-7.
Modica CM, Bergsland N, Dwyer MG, Ramasamy DP, Carl E, Zivadinov R, Benedict RH. (2016) Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Jan), 22(1): 36-42.
Motl RW, Zivadinov R, Bergsland N, Benedict RH. (2016) Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study. Neurodegenerative disease management (Jan), 6(1): 23-9.
Revenaz A, Ruggeri M, Laganà M, Bergsland N, Groppo E, Rovaris M, Fainardi E. (2016) A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures. BMC medical imaging (Jan), 16: 4. doi:10.1186/s12880-016-0108-1
Tao Y, Zhang X, Zivadinov R, Dwyer MG, Kennedy C, Bergsland N, Ramasamy D, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B, Markovic-Plese S. (2015) Immunologic and MRI markers of the therapeutic effect of IFN-ß-1a in relapsing-remitting MS. Neurology(R) neuroimmunology & neuroinflammation (Dec), 2(6): e176. doi:10.1212/NXI.0000000000000176
Bergsland N, Laganà MM, Tavazzi E, Caffini M, Tortorella P, Baglio F, Baselli G, Rovaris M. (2015) Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Dec), 21(14): 1771-80.
Dwyer MG, Zivadinov R, Tao Y, Zhang X, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Weinstock-Guttman B, Hayward B, Dangond F, Markovic-Plese S. (2015) Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial. BMC neurology (Nov), 15: 232. doi:10.1186/s12883-015-0488-9
Cesar B, Dwyer MG, Shucard JL, Polak P, Bergsland N, Benedict RH, Weinstock-Guttman B, Shucard DW, Zivadinov R. (2015) Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus. AJNR. American journal of neuroradiology (Oct), 36(10): 1874-83. doi:10.3174/ajnr.A4354
Varosanec M, Uher T, Horakova D, Hagemeier J, Bergsland N, Tyblova M, Seidl Z, Vaneckova M, Krasensky J, Dwyer MG, Havrdova E, Zivadinov R. (2015) Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome. AJNR. American journal of neuroradiology (Aug), 36(8): 1457-64. doi:10.3174/ajnr.A4330
Uher T, Horakova D, Kalincik T, Bergsland N, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. (2015) Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon ß-1a. European journal of neurology (Jul), 22(7): 1113-23.
Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B, Dangond F. (2015) Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly. Journal of neuroimmunology (Apr), 281: 44-50.
Tavazzi E, Laganà MM, Bergsland N, Tortorella P, Pinardi G, Lunetta C, Corbo M, Rovaris M. (2015) Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Mar), 36(3): 371-7.
Zivadinov R, Dwyer M, Markovic-Plese S, Hayward B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Dangond F, Weinstock-Guttman B. (2015) A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis. Therapeutic advances in neurological disorders (Mar), 8(2): 59-70. doi:10.1177/1756285615572953
Modica CM, Zivadinov R, Dwyer MG, Bergsland N, Weeks AR, Benedict RH. (2015) Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis. AJNR. American journal of neuroradiology (Jan), 36(1): 57-62. doi:10.3174/ajnr.A3998
Mak E, Bergsland N, Dwyer MG, Zivadinov R, Kandiah N. (2014) Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis. AJNR. American journal of neuroradiology (Dec), 35(12): 2257-64. doi:10.3174/ajnr.A4055
Uher T, Benedict RH, Horakova D, Bergsland N, Dusankova JB, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. (2014) Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment. Journal of the neurological sciences (Dec), 347(1-2): 229-34.
Beggs CB, Magnano C, Shepherd SJ, Marr K, Valnarov V, Hojnacki D, Bergsland N, Belov P, Grisafi S, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R. (2014) Aqueductal cerebrospinal fluid pulsatility in healthy individuals is affected by impaired cerebral venous outflow. Journal of magnetic resonance imaging : JMRI (Nov), 40(5): 1215-22.
Hagemeier J, Heininen-Brown M, Gabelic T, Guttuso T, Silvestri N, Lichter D, Fugoso LE, Bergsland N, Carl E, Geurts JJ, Weinstock-Guttman B, Zivadinov R. (2014) Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders. AJNR. American journal of neuroradiology (Oct), 35(10): 1916-23. doi:10.3174/ajnr.A3969
Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen JP, Farbu E, Zivadinov R. (2014) Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. Journal of neurology, neurosurgery, and psychiatry (Oct), 85(10): 1109-15.
Uher T, Blahova-Dusankova J, Horakova D, Bergsland N, Tyblova M, Benedict RH, Kalincik T, Ramasamy DP, Seidl Z, Hagermeier J, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. (2014) Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. Journal of neurology (Sep), 261(9): 1735-44.
Browne RW, Weinstock-Guttman B, Zivadinov R, Horakova D, Bodziak ML, Tamaño-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Qu J, Havrdova E, Ramanathan M. (2014) Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study. The Journal of steroid biochemistry and molecular biology (Sep), 143: 424-33.
Browne RW, Weinstock-Guttman B, Horakova D, Zivadinov R, Bodziak ML, Tamaño-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Havrdova E, Ramanathan M. (2014) Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. Journal of neurology, neurosurgery, and psychiatry (Aug), 85(8): 859-64.
Zivadinov R, Bergsland N, Cappellani R, Hagemeier J, Melia R, Carl E, Dwyer MG, Lincoff N, Weinstock-Guttman B, Ramanathan M. (2014) Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients. European journal of neurology (Aug), 21(8): 1137-e61.
Zivadinov R, Chin J, Horakova D, Bergsland N, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Hagemeier J, Tyblova M, Carl E, Krasensky J, Vaneckova M, Seidl Z, Dwyer MG, Havrdova E, Ramanathan M. (2014) Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set study. Journal of neuroimmunology (Aug), 273(1-2): 58-64.
Goldberg H, Weinstock A, Bergsland N, Dwyer MG, Farooq O, Sazgar M, Poloni G, Treu C, Weinstock-Guttman B, Ramanathan M, Zivadinov R. (2014) MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy. BMC neurology (Jun), 14: 131. doi:10.1186/1471-2377-14-131
Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R. (2014) Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study. AJNR. American journal of neuroradiology (May), 35(5): 912-9. doi:10.3174/ajnr.A3788
Dwyer MG, Bergsland N, Zivadinov R. (2014) Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model. NeuroImage (Apr), 90: 207-17.
Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R. (2014) Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome. Journal of the neurological sciences (Mar), 338(1-2): 128-34.
Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B. (2014) Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study. PloS one (Jan), 9(3): e91098. doi:10.1371/journal.pone.0091098
Di Stefano AL, Bergsland N, Berzero G, Farina L, Rognone E, Gastaldi M, Aquino D, Frati A, Tomasello F, Ceroni M, Marchioni E, Bastianello S. (2014) Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area. BioMed research international (Jan), 2014: 154350. doi:10.1155/2014/154350
Chung CP, Beggs C, Wang PN, Bergsland N, Shepherd S, Cheng CY, Ramasamy DP, Dwyer MG, Hu HH, Zivadinov R. (2014) Jugular venous reflux and white matter abnormalities in Alzheimer's disease: a pilot study. Journal of Alzheimer's disease : JAD (Jan), 39(3): 601-9.
Chung CP, Beggs C, Wang PN, Bergsland N, Shepherd S, Cheng CY, Ramasamy DP, Dwyer MG, Hu HH, Zivadinov R. (2014) Jugular venous reflux and white matter abnormalities in Alzheimer's disease: a pilot study. Journal of Alzheimer's disease : JAD (Jan), 39(3): 601-9.
Uher T, Horakova D, Bergsland N, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. (2014) MRI correlates of disability progression in patients with CIS over 48 months. NeuroImage. Clinical (Jan), 6: 312-9. doi:10.1016/j.nicl.2014.09.015
Gabelic T, Weinstock-Guttman B, Melia R, Lincoff N, Masud MW, Kennedy C, Brinar V, Ramasamy DP, Carl E, Bergsland N, Ramanathan M, Zivadinov R. (2013) Retinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patients. Clinical neurology and neurosurgery (Dec), 115 Suppl 1: S49-54.
Dolezal O, Gabelic T, Horakova D, Bergsland N, Dwyer MG, Seidl Z, Krasensky J, Ramasamy DP, Vaneckova M, Havrdova E, Zivadinov R. (2013) Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study. Clinical neurology and neurosurgery (Dec), 115 Suppl 1: S42-8.
Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R, . (2013) Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC neurology (Nov), 13: 173. doi:10.1186/1471-2377-13-173
Weinstock-Guttman B, Zivadinov R, Horakova D, Havrdova E, Qu J, Shyh G, Lakota E, O'Connor K, Badgett D, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Ramanathan M. (2013) Lipid profiles are associated with lesion formation over 24 months in interferon-ß treated patients following the first demyelinating event. Journal of neurology, neurosurgery, and psychiatry (Nov), 84(11): 1186-91.
Weinstock-Guttman B, Horakova D, Zivadinov R, Tamaño-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Havrdova E, Ramanathan M. (2013) Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes. Journal of neuroimmunology (Oct), 263(1-2): 121-7.
Beggs C, Chung CP, Bergsland N, Wang PN, Shepherd S, Cheng CY, Dwyer MG, Hu HH, Zivadinov R. (2013) Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease. BMC neurology (Oct), 13: 157. doi:10.1186/1471-2377-13-157
Zivadinov R, Bergsland N, Dolezal O, Hussein S, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Potts JA, Kalincik T, Havrdová E, Horáková D. (2013) Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years. AJNR. American journal of neuroradiology (Oct), 34(10): 1931-9. doi:10.3174/ajnr.A3503
Benedict RH, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B, Geurts JJ, Zivadinov R. (2013) Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Multiple sclerosis (Houndmills, Basingstoke, England) (Oct), 19(11): 1478-84.
Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M. (2013) Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (Oct), 84(10): 1075-81.
Wack DS, Dwyer MG, Bergsland N, Ramasamy D, Di Perri C, Ranza L, Hussein S, Magnano C, Seals K, Zivadinov R. (2013) Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI. BMC medical imaging (Sep), 13: 29. doi:10.1186/1471-2342-13-29
Zivadinov R, Havrdová E, Bergsland N, Tyblova M, Hagemeier J, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Carl E, Kalincik T, Horáková D. (2013) Thalamic atrophy is associated with development of clinically definite multiple sclerosis. Radiology (Sep), 268(3): 831-41.
Zivadinov R, Shucard JL, Hussein S, Durfee J, Cox JL, Bergsland N, Dwyer MG, Benedict RH, Ambrus J, Shucard DW. (2013) Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement. Lupus (Jun), 22(7): 675-83.
Benedict RH, Schwartz CE, Duberstein P, Healy B, Hoogs M, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R. (2013) Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis. Psychosomatic medicine (Apr), 75(3): 253-61.
Hagemeier J, Yeh EA, Brown MH, Bergsland N, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R. (2013) Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Apr), 19(5): 567-76.
Zivadinov R, Tekwe C, Bergsland N, Dolezal O, Havrdova E, Krasensky J, Dwyer MG, Seidl Z, Ramasamy DP, Vaneckova M, Horakova D. (2013) Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study. Multiple sclerosis international (Jan), 2013: 231345. doi:10.1155/2013/231345
Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Qu J, Tamaño-Blanco M, Badgett D, Tyblova M, Bergsland N, Hussein S, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Dwyer MG, Zhang M, Yu H, Duan X, Kalincik T, Ramanathan M. (2013) Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. PloS one (Jan), 8(1): e53996. doi:10.1371/journal.pone.0053996
Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR, Kennedy C, Carl E, Dwyer MG, Minagar A, Zivadinov R. (2013) Gray matter SWI-filtered phase and atrophy are linked to disability in MS. Frontiers in bioscience (Elite edition) (Jan), 5(2): 525-32.
Beyer MK, Bronnick KS, Hwang KS, Bergsland N, Tysnes OB, Larsen JP, Thompson PM, Somme JH, Apostolova LG. (2013) Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry (Jan), 84(1): 23-8. doi:10.1136/jnnp-2012-303054
Hagemeier J, Dwyer MG, Bergsland N, Schweser F, Magnano CR, Heininen-Brown M, Ramasamy DP, Carl E, Kennedy C, Melia R, Polak P, Deistung A, Geurts JJ, Reichenbach JR, Zivadinov R. (2013) Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals. AJNR. American journal of neuroradiology (Jan), 34(11): 2144-51. doi:10.3174/ajnr.A3569
Zivadinov R, Cutter G, Marr K, Ramanathan M, Benedict RH, Bergsland N, Morgan C, Carl E, Hojnacki D, Yeh EA, Willis L, Cherneva M, Kennedy C, Dwyer MG, Weinstock-Guttman B. (2012) No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis. AJNR. American journal of neuroradiology (Nov), 33(10): 1913-7. doi:10.3174/ajnr.A3112
Zivadinov R, Ramanathan M, Ambrus J, Hussein S, Ramasamy DP, Dwyer MG, Bergsland N, Minagar A, Weinstock-Guttman B. (2012) Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study. Neurological research (Oct), 34(8): 761-9.
Magnano C, Schirda C, Weinstock-Guttman B, Wack DS, Lindzen E, Hojnacki D, Bergsland N, Kennedy C, Belov P, Dwyer MG, Poloni GU, Beggs CB, Zivadinov R. (2012) Cine cerebrospinal fluid imaging in multiple sclerosis. Journal of magnetic resonance imaging : JMRI (Oct), 36(4): 825-34.
Bergsland N, Horakova D, Dwyer MG, Dolezal O, Seidl ZK, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. (2012) Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis. AJNR. American journal of neuroradiology (Sep), 33(8): 1573-8. doi:10.3174/ajnr.A3086
Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R. (2012) Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR. American journal of neuroradiology (Sep), 33(8): 1596-601. doi:10.3174/ajnr.A3030
Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B. (2012) Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNß-1a in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Aug), 18(8): 1125-34.
Wack DS, Dwyer MG, Bergsland N, Di Perri C, Ranza L, Hussein S, Ramasamy D, Poloni G, Zivadinov R. (2012) Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates. BMC medical imaging (Jul), 12: 17. doi:10.1186/1471-2342-12-17
Hagemeier J, Heininen-Brown M, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Weinstock-Guttman B, Dwyer MG, Zivadinov R. (2012) Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study. Journal of magnetic resonance imaging : JMRI (Jul), 36(1): 73-83.
Zivadinov R, Hussein S, Bergsland N, Minagar A, Dwyer MG. (2012) Magnetization transfer imaging of acute black holes in patients on glatiramer acetate. Frontiers in bioscience (Elite edition) (Jan), 4(4): 1496-504.
Zivadinov R, Hojnacki D, Hussein S, Bergsland N, Carl E, Durfee J, Dwyer MG, Kennedy C, Weinstock-Guttman B. (2012) Comparison of standard 1.5 T vs. 3 T optimized protocols in patients treated with glatiramer acetate. A serial MRI pilot study. International journal of molecular sciences (Jan), 13(5): 5659-5673. doi:10.3390/ijms13055659
Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG. (2012) Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. NeuroImage (Jan), 59(1): 331-9.
Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH. (2012) Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. Journal of neurology (Jan), 259(1): 139-46.
Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N, Ramanathan M. (2011) Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. Journal of neuroinflammation (Oct), 8: 127. doi:10.1186/1742-2094-8-127
Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, Bergsland N, Hojnacki D, Kennedy C, Beggs CB, Dwyer MG, Weinstock-Guttman B. (2011) Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC neurology (Oct), 11: 128. doi:10.1186/1471-2377-11-128
Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, Bergsland N, Hojnacki D, Kennedy C, Beggs CB, Dwyer MG, Weinstock-Guttman B. (2011) Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. BMC neurology (Oct), 11: 128. doi:10.1186/1471-2377-11-128
Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Ramanathan M. (2011) HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event. Journal of neuroimmunology (Jul), 236(1-2): 76-80.
Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F, Zivadinov R. (2011) Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report. BMC medicine (Mar), 9: 22. doi:10.1186/1741-7015-9-22
Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M, Ramanathan M. (2011) Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. Journal of neurology, neurosurgery, and psychiatry (Feb), 82(2): 189-95.
Ramasamy DP, Ramanathan M, Cox JL, Antulov R, Weinstock-Guttman B, Bergsland N, Benedict RH, Dwyer MG, Minagar A, Zivadinov R. (2011) Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study. Pathophysiology : the official journal of the International Society for Pathophysiology (Feb), 18(1): 53-60.
Zivadinov R, Schirda C, Dwyer MG, Haacke ME, Weinstock-Guttman B, Menegatti E, Heininen-Brown M, Magnano C, Malagoni AM, Wack DS, Hojnacki D, Kennedy C, Carl E, Bergsland N, Hussein S, Poloni G, Bartolomei I, Salvi F, Zamboni P. (2010) Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. International angiology : a journal of the International Union of Angiology (Apr), 29(2): 158-75.
Zamboni P, Menegatti E, Weinstock-Guttman B, Schirda C, Cox JL, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Dwyer MG, Bergsland N, Galeotti R, Hussein S, Bartolomei I, Salvi F, Ramanathan M, Zivadinov R. (2010) CSF dynamics and brain volume in multiple sclerosis are associated with extracranial venous flow anomalies: a pilot study. International angiology : a journal of the International Union of Angiology (Apr), 29(2): 140-8.
Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, Dwyer MG, Hussein S, Bergsland N, Munschauer FE, Zivadinov R. (2010) Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology (Feb), 74(7): 538-44.
Horáková D, Kýr M, Havrdová E, Doležal O, Lelková P, Pospíšilová L, Bergsland N, Dwyer MG, Cox JL, Hussein S, Seidl Z, Vanecková M, Krásenský J, Zivadinov R. (2010) Apolipoprotein E e4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study. Folia biologica (Jan), 56(6): 242-51.
Dalaker TO, Larsen JP, Bergsland N, Beyer MK, Alves G, Dwyer MG, Tysnes OB, Benedict RH, Kelemen A, Bronnick K, Zivadinov R. (2009) Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Movement disorders : official journal of the Movement Disorder Society (Nov), 24(15): 2233-41.
Havrdova E, Zivadinov R, Krasensky J, Dwyer MG, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox JL, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M, Horakova D. (2009) Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) (Aug), 15(8): 965-76.
Dwyer M, Bergsland N, Hussein S, Durfee J, Wack D, Zivadinov R. (2009) A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio. Journal of the neurological sciences (Jul), 282(1-2): 86-95.
Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M, Zivadinov R. (2009) Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study. Journal of the neurological sciences (Jul), 282(1-2): 112-9.
Antulov R, Weinstock-Guttman B, Cox JL, Hussein S, Durfee J, Caiola C, Dwyer MG, Bergsland N, Abdelrahman N, Stosic M, Hojnacki D, Munschauer FE, Miletic D, Zivadinov R. (2009) Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Multiple sclerosis (Houndmills, Basingstoke, England) (Mar), 15(3): 345-54.
Zamboni P, Menegatti E, Weinstock-Guttman B, Schirda C, Cox JL, Malagoni AM, Hojanacki D, Kennedy C, Carl E, Dwyer MG, Bergsland N, Galeotti R, Hussein S, Bartolomei I, Salvi F, Zivadinov R. (2009) The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Functional neurology (Jan), 24(3): 133-8.
Dwyer MG, Bergsland N, Saluste E, Sharma J, Jaisani Z, Durfee J, Abdelrahman N, Minagar A, Hoque R, Munschauer FE, Zivadinov R. (2008) Application of hidden Markov random field approach for quantification of perfusion/diffusion mismatch in acute ischemic stroke. Neurological research (Oct), 30(8): 827-34.
Zivadinov R, Bergsland N, Stosic M, Sharma J, Nussenbaum F, Durfee J, Hani N, Abdelrahman N, Jaisani Z, Minagar A, Hoque R, Munschauer FE, Dwyer MG. (2008) Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis. Neurological research (Oct), 30(8): 816-26.
Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R. (2008) Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. Journal of neurology, neurosurgery, and psychiatry (Apr), 79(4): 407-14.
Dolezal O, Dwyer MG, Horakova D, Havrdova E, Minagar A, Balachandran S, Bergsland N, Seidl Z, Vaneckova M, Fritz D, Krasensky J, Zivadinov R. (2007) Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis. International review of neurobiology (Jan), 79: 475-89.

See all (255 more)

Professional Memberships:

International multiple sclerosis cognition society (IMSCOGS) (2014–present)
Upsilon Pi Epsilon - International Computer Science Honor Society (2012–present)
International Society for Magnetic Resonance in Medicine (ISMRM) (2009–present)
American Academy of Neurology (AAN) (2008–present)

Presentations:

"Imaging the Choroid Plexus" Annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting (2024)
"Imaging neuroinflammation of the choroid plexus in multiple sclerosis" Imaging Barriers of the CNS at the North American Imaging in MS (NAIMS) Cooperative Workshop (2024)
"Moving into the Spotlight: The Choroid Plexus in Neurological Diseases and Psychiatric Disorders" Neuroscience Seminar Series - Neuroscience Program at University at Buffalo (2024)
"State of Science/Institutional Perspectives in Neurology: Multiple Sclerosis: Role of Artificial Intelligence in Multiple Sclerosis" NeurologyLive Webcast (2023)
"New Imaging Biomarkers in Parkinson Disease" 7th Rijeka Forum on Neurodegenerative Disease (2023)
"Moving into the Spotlight: The Choroid Plexus in Neurological Diseases of the Central Nervous System" Grand Rounds at Department of Neurology - University at Buffalo (2023)
"Advanced imaging in neurological diseases" Seminar for the Department of Neurology at Prague University (2022)
"Regions important to monitor for atrophy in MS: Disability versus cognition" Annual International Multiple Sclerosis Cognition Society (IMSCOGS) meeting (2022)
"Advanced Imaging in Neurological Diseases: Mind the Gap" Grand Rounds at Department of Neurology - University at Buffalo (2022)
"Advanced MRI techniques in multiple sclerosis: multimodal assessment of WM and GM damage mechanisms" Seminar series at Fondazione Don Gnocchi (2016)
"Multicenter MR studies: Challenges and Possibilities" Seminar on multi-center MRI studies at Oslo University (2014)
"Morphological and multimodal brain analysis" Imaging seminar at Politecnico di Milano (2014)
"Gray Matter Pathology in Multiple Sclerosis" Grand Rounds at Department of Neurology - University at Buffalo (2011)

See all (3 more)

Service Activities:

NRS 524 - Quantitative Neuroanatomy; Lecturer (2024)
Neuroscience of Social Behavior: Bridging the Mind and Society; Ad-hoc book chapter reviewer (2024)
Faculty Council; Alternate (2024–present)
MS Australia; Grant reviewer (2024–present)
Department of Neurology; Mentor for PGY4 Resident Research Program (2024–present)
Amsterdam University; Member of reading committee for evaluating the PhD project of Samantha Noteboom (2024)
PhD Program in Biomedical Sciences Admissions Committee; Committee Member for Neuroscience (2024–present)
NRS 524 - Quantitative Neuroanatomy; Lecturer (2023)
US Department of Defense CDMRP Multiple Sclerosis Research; Grant reviewer (2023)
Department of Neurology; Judge for Resident Research Day (2023)
Sydney University; Member of the PhD examination committee for Christina Maher (2023)
International Society for Magnetic Resonance in Medicine (ISMRM); Moderator for multiple sclerosis oral session (2022)
BMC Neurology; Academic editor (2021–present)
Neurology; Ad-hoc manuscript reviewer (2021–present)
MSBASE-XNAT imaging repository; Imaging advisor on project control board (2020–present)
MSBase MRI Steering Committee; Member (2020–present)
Frontiers in Neurology; Associate editor (2020–present)
Journal of Neuroimaging; Section editor for multiple sclerosis (2019–present)
PLOS One; Academic editor (2019–present)
Movement Disorders; Ad-hoc manuscript reviewer (2019–present)
Journal of Magnetic Resonance Imaging; Associate editor (2018–present)
Grant reviewer; Swiss National Science Foundation (2017–2019)
Oslo University; Member of the PhD evaluation commission for Piotr Wladyslaw Sowa, MD (2017)
Journal of Magnetic Resonance Imaging; Ad-hoc manuscript reviewer (2016–present)
International Society for Magnetic Resonance in Medicine (ISMRM); Abstract reviewer for annual meeting (2016–present)
Human brain mapping; Ad-hoc manuscript reviewer (2016–present)
Multiple Sclerosis Journal; Ad-hoc manuscript reviewer (2015–present)
Journal of Neurology, Neurosurgery, and Psychiatry; Ad-hoc manuscript reviewer (2015–present)

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

scroll-out

Contact Information

77 Goodell St. Suite 440D
Buffalo, New York 14203
npb5@buffalo.edu

View map

Niels P. Bergsland PhD

Niels P. Bergsland
PhD

Specialty/Research Focus

Professional Summary:

Education and Training:

Employment:

Awards and Honors:

Research Centers:

UB 2020 Strategic Strengths:

Journal Articles:

Professional Memberships:

Presentations:

Service Activities:

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

PhD Program in Biomedical Sciences

Connect With Us

Jacobs School of Medicine and Biomedical Sciences

About The School

Education and Training

Centers and Affiliations

Find People

Resources by Audience

Alumni and Friends

Research Facilities and Services

Get Involved

Learning Resources

Support Services

Site Tools